<code id='76FA6D0E38'></code><style id='76FA6D0E38'></style>
    • <acronym id='76FA6D0E38'></acronym>
      <center id='76FA6D0E38'><center id='76FA6D0E38'><tfoot id='76FA6D0E38'></tfoot></center><abbr id='76FA6D0E38'><dir id='76FA6D0E38'><tfoot id='76FA6D0E38'></tfoot><noframes id='76FA6D0E38'>

    • <optgroup id='76FA6D0E38'><strike id='76FA6D0E38'><sup id='76FA6D0E38'></sup></strike><code id='76FA6D0E38'></code></optgroup>
        1. <b id='76FA6D0E38'><label id='76FA6D0E38'><select id='76FA6D0E38'><dt id='76FA6D0E38'><span id='76FA6D0E38'></span></dt></select></label></b><u id='76FA6D0E38'></u>
          <i id='76FA6D0E38'><strike id='76FA6D0E38'><tt id='76FA6D0E38'><pre id='76FA6D0E38'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:756
          Ed Silverman on the Breakthrough Summit stage in 2023.
          STAT's Ed Silverman on stage at the STAT Breakthrough Summit in 2023. Sarah Gonzalez for STAT

          In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. On STAT+ Connect, you can find job postings; comment on STAT articles (since we have closed comments on article pages); discuss industry events with other people who work in biotech, pharma, public health advocacy, PR, and more; read insights and exclusive material posted by STAT reporters and editors; and watch events, including live interviews and text-based Ask Me Anything chats.

          Last week, Ed Silverman, AKA Pharmalot, hosted an AMA titled “Stump Pharmalot.” During the AMA, Ed discussed gene therapy, his proudest career moments, what he took in high school instead of chemistry, coffee (or, as he calls it, “cups of stimulation”), and more.

          advertisement

          Below, you can find a lightly edited transcript of the conversation.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.
          A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

          AdobeLastweek,theWashingtonPostpublishedanop-edbyformerCDCDirectorTomFriedentitled,“It’stheworld’sle

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          Gilead might be held responsible for not developing a drug

          JustinSullivan/GettyImagesTheassaultonthedevelopmentofnewlifesavingtherapiescontinuesapace.Recently,